These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experimental and clinical trials with BCG immunotherapy. Sparks FC, Silverstein MJ, Hunt JS, O'Connell TX, Lee YT, Pilch YH, Haskell CM, Morton DL. Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024 [No Abstract] [Full Text] [Related]
3. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors. Yron I, Weiss DW, Robinson E, Cohen D, Adelberg MG, Mekori T, Haber M. Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523 [No Abstract] [Full Text] [Related]
4. Effects on tumor growth in vivo by manipulation of the tumor immune response. Sjögren HO. Johns Hopkins Med J Suppl; 1974 Dec; 3():51-60. PubMed ID: 4370816 [No Abstract] [Full Text] [Related]
5. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. II. In vitro cytotoxicity of lymphoid cells against normal and malignant syngeneic cells and against normal allogeneic cells. Olsson L, Ebbesen P. J Immunol; 1979 Mar; 122(3):781-6. PubMed ID: 376706 [No Abstract] [Full Text] [Related]
7. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy. Vaage J. Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431 [Abstract] [Full Text] [Related]
8. Immunotherapy of guinea pig cancer with BCG. Zbar B. Johns Hopkins Med J Suppl; 1974 Dec; 3():121-30. PubMed ID: 4608693 [No Abstract] [Full Text] [Related]
9. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer. Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945 [No Abstract] [Full Text] [Related]
10. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer. Mathé G, Halle-Pannenko O, Bourut C, Hiu IJ. Johns Hopkins Med J Suppl; 1974 Apr; 3():85-102. PubMed ID: 4154074 [No Abstract] [Full Text] [Related]
11. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG. Tracey DE, Wolfe SA, Durdik JM, Henney CS. J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748 [No Abstract] [Full Text] [Related]